Physician profile
Jeffrey Smith
NPI 1962504357
$2,627.65
in general payments reported to CMS, 2019-2025
13 companies · $273 in 2025
The $273 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $577 · 2023: $381 · 2024: $1,397 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,091 · Travel and Lodging: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,090.64 |
| Travel and Lodging | $960.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,454.60 | 2024-2025 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Mentor Worldwide LLC | $139.00 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $139.00 | 2023 | Natrelle Saline-Filled Breast Implants |
| Davol INC. | $137.29 | 2019 | |
| Acell, INC. | $121.35 | 2019 | |
| Olympus America INC. | $113.85 | 2019 | |
| Angiodynamics, INC. | $103.12 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $101.20 | 2019 | |
| Janssen Pharmaceuticals, INC | $95.02 | 2024 | Xarelto |
| Merit Medical Systems INC | $89.72 | 2025 | Savi Scout |
| Endomagnetics Ltd | $70.48 | 2023 | Magseed, Magtrace |
| Intuitive Surgical, INC. | $32.43 | 2023 | Da Vinci Surgical System |
| Stryker Corporation | $30.59 | 2025 | Spy-Phi System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.